Mathias Arnold elected European pharmacists’ president for 2027
PGEU’s General Assembly has elected German pharmacist Mathias Arnold as president for 2027. He will succeed Poland’s Dr Mikolaj Konstanty.
Image: ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.
Skin cancer prevention: BVDD continues May 2026 campaign
BVDD will continue its skin cancer prevention month in May 2026. The focus is on UV protection, early detection and practice-ready tools.
Biogen completes acquisition of Apellis Pharmaceuticals
Biogen has completed its acquisition of Apellis. The deal adds SYFOVRE and EMPAVELI and is positioned to support Biogen’s nephrology expansion.
Health system under pressure: sustainability as a lever for prevention
At WeACT Con, experts discussed how prevention and environmental health can reduce risks and help stabilize healthcare, from funding ideas to guidance.
Orifarm appoints Pierre Bourdage to Board of Directors
Orifarm has appointed Pierre Bourdage to its Board of Directors, effective May 1. The former Sandoz CCO brings international pharma expertise.
Tyra Biosciences and BCAN establish UTUC Awareness Day
Tyra Biosciences and BCAN set May 21 as UTUC Awareness Day, highlighting the rare cancer’s burden and the need for continued research.
Ryan Reynolds launches Parkinson’s non-motor symptom campaign
Ryan Reynolds and Acadia launched “More to Parkinson’s” to raise awareness of hallucinations and delusions in Parkinson’s and improve patient-doctor dialogue.
Bedrocan flower to be offered as Becanex PIEX raw extract for compounding
Bedrocan and Becanex plan PIEX Bedrocan 70% THC as a raw extract for pharmacy compounding, with shipments expected to start in summer 2026.
Tarsus teams up with John Cena to raise awareness of Demodex blepharitis
Tarsus has launched an awareness partnership with John Cena on Demodex blepharitis, covering symptoms, routine diagnosis and XDEMVY treatment.
Christian Mias to succeed Andreas Reisse as SCHOTT Pharma CEO
SCHOTT Pharma appoints Christian Mias as CEO effective 1 May 2026. Andreas Reisse will retire as planned at the end of April 2026.